William C. Ratcliff is a Professor in the School of Biological Sciences at Georgia Institute of Technology and serves as the Director of the Interdisciplinary Ph.D. Program in Quantitative Biosciences (QBioS). He is widely recognized for his research on the evolution of multicellularity, social evolution, and bet hedging, combining experimental and theoretical approaches. His work often explores how single-celled organisms transition to multicellular life forms, with notable studies involving yeast models.

Dr. Ratcliff earned his Ph.D. from the University of Minnesota in 2011, where he conducted research on microbial ecology and evolution. His groundbreaking work includes the experimental evolution of multicellularity, which has been featured in high-impact journals such as Nature Communications and Proceedings of the National Academy of Sciences. He has also contributed to understanding ecological and evolutionary dynamics in microbial communities.

At Georgia Tech, Dr. Ratcliff leads an active research lab focused on evolutionary biology and biophysics, mentoring students and postdoctoral researchers. His contributions to science include both fundamental insights into multicellular evolution and applications in biotechnology.

Ricard Solé is an ICREA research professor at the Universitat Pompeu Fabra, where he heads the Complex Systems Lab. He holds degrees in Physics and Biology from the University of Barcelona and a PhD in Physics from the Polytechnic University of Catalonia. Prof. Solé is also an External Professor at the Santa Fe Institute and a fellow of the European Center for Living Technology. His research focuses on the evolutionary origins of complex systems, synthetic biology, and unstable evolutionary dynamics. He has published over 250 scientific papers and is a frequent keynote speaker at international conferences. Solé is known for his work on synthetic major transitions and terraforming endangered ecosystems.

Eric Schwitzgebel, an esteemed philosopher at the University of California, Riverside, is renowned for his groundbreaking work at the intersection of empirical psychology and philosophy of mind. With a PhD from the University of California, Berkeley, under the mentorship of Elisabeth A. Lloyd, Alison Gopnik, and John Searle, Schwitzgebel has become a leading voice in contemporary philosophical discourse.

His research focuses on the behavior of philosophers, particularly ethicists, using empirical methods to explore whether ethicists exhibit heightened ethical conduct. Through seminal studies, including a notable 2009 investigation into the prevalence of ethics books in academic libraries, Schwitzgebel challenges assumptions about the ethical behavior of philosophers.

Contrary to prevailing beliefs, his research reveals that ethicists do not demonstrate significantly different ethical behavior compared to other disciplines. Moreover, he illuminates the susceptibility of moral beliefs among professional philosophers to extraneous influences, prompting a critical reevaluation of ethical thought and behavior.

Eric Schwitzgebel's work continues to inspire interdisciplinary dialogue and reshape our understanding of moral philosophy, underscoring the complex interplay between cognition, social context, and ethical decision-making. As a distinguished academic and prolific author, he leaves an indelible mark on the philosophical landscape, urging us to explore the intricacies of human morality with renewed clarity and insight.

Katrin Preller received her PhD in Psychology and Neuroscience from University of Zurich, Switzerland in 2013. Her research interests are centered around the neuropharmacology of emotional and cognitive processes such as social cognition in health and psychiatric illnesses, as well as (pharmacological) neuroimaging analysis methodology. She is particularly interested in substance use disorders as well the role of the serotonin system in emotion and cognition. To elucidate the role of 5-HT2A/1A receptor functions in human cognition she uses pharmacological challenges mainly with psilocybin and LSD.

Russell Foster is Professor of Circadian Neuroscience and the Head of the Department of Ophthalmology. He is also a Nicholas Kurti Senior Fellow at Brasenose College. Prior to this, Russell was at Imperial College where Russell was Chair of Molecular Neuroscience within the Faculty of Medicine. Russell Foster’s research spans basic and applied circadian and photoreceptor biology.

He received his education at the University of Bristol under the supervision of Professor Sir Brian Follett. from 1988–1995 he was a member of the National Science Foundation Center for Biological Rhythms at the University of Virginia and worked closely with Michael Menaker. In 1995 he returned to the UK and established his group at Imperial College. For his discovery of non-rod, non-cone ocular photoreceptors he has been awarded the Honma prize (Japan), Cogan award (USA), and Zoological Society Scientific & Edride-Green Medals (UK). He is the co-author of “Rhythms of Life” a popular science book on circadian rhythms.

Juliana Schroeder is an Associate Professor at Berkeley Haas, holding the Harold Furst Chair in Management Philosophy and Values. She explores how language shapes social perception and interaction. Her research, featured in top journals and media outlets, has earned recognition from the NSF, APS, and APA. Juliana co-founded the Psychology of Technology Institute and teaches Negotiations and Conflict Resolution. She holds degrees from the University of Virginia and the University of Chicago.

Stacey B. Armstrong, PhD is a senior researcher and psychologist at the Center for Psychedelic Drug Research and Education (CPDRE) at The Ohio State University College of Social Work. She earned her Ph.D. at Bowling Green State University after completing a clinical internship at the University of Michigan in Ann Arbor, MI. Her clinical fellowship at the Traumatic Stress Center in Akron, OH, emphasized the utilization of evidence-based treatments for posttraumatic stress disorder (PTSD) among veterans and civilians, including cognitive processing therapy (CPT) and prolonged exposure (PE). She also completed a research fellowship at The Ohio State University evaluating the safety and efficacy of psilocybin, a novel investigational psychedelic drug, in treating treatment-resistant PTSD among US military veterans. In addition to her work with PTSD, Dr. Armstrong is also collaborating on a clinical trial investigating the safety and efficacy of psilocybin in treating depression among lung cancer patients. She is also investigating the patterns of use and acute subjective effects of psychoactive substances in clinical and non-clinical settings, measuring the attitudes and beliefs about psychedelic-assisted therapies among mental health professionals, and helping to develop a global registry for opioid use disorder patients who have sought psychedelic therapy in international locations to obtain real-world evidence on the safety and effectiveness of ibogaine as an addiction treatment. She has a particular interest in the subjective effects of psychedelics and their impact on treatment outcomes, as well as how psychedelic-assisted therapies might benefit populations currently excluded from clinical trials.

William Egginton is a distinguished literary critic and philosopher renowned for his insightful explorations of theatricality, fictionality, literary criticism, psychoanalysis, ethics, religious moderation, and theories of mediation. With a commitment to interdisciplinary inquiry, Egginton's work reflects a nuanced understanding of the complexities of human experience. His contributions extend to the realms of psychoanalysis and ethics, demonstrating a thoughtful engagement with the intricacies of these fields. A prolific writer, Egginton's impact reaches beyond academia, fostering dialogue and understanding in areas often marked by discord, such as religious moderation. His concise yet profound analyses showcase a keen intellect, making him a respected voice in contemporary literary criticism and philosophy.